E
Arrowhead Pharmaceuticals, Inc. ARWR
$21.33 $0.582.80% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -147.31% 314.02% -1.49% 0.15% -36.31%
Total Depreciation and Amortization 2.28% 16.22% 4.18% 5.08% 5.68%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -15.11% 30.95% 42.64% -21.60% 3.67%
Change in Net Operating Assets -139.45% 711.90% -193.56% -67.73% 631.71%
Cash from Operations -133.63% 414.52% -6.60% -18.89% -24.94%
Capital Expenditure 55.37% 29.52% 69.06% -68.10% 57.60%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 134.65% -591.46% 142.50% -1,028.28% 109.11%
Cash from Investing 133.65% -646.37% 134.50% -3,307.99% 102.58%
Total Debt Issued -- -- -- -- --
Total Debt Repaid 67.02% -- -- -- --
Issuance of Common Stock -99.91% 38,386.91% 184.30% -42.38% -99.91%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -100.00% 738.16% -106.27% --
Cash from Financing -146.20% 347.72% -94.70% 672.20% -88.30%
Foreign Exchange rate Adjustments 123.13% -491.18% -101.57% 2,044.39% -957.69%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -142.42% 370.15% -246.60% 157.09% -183.91%